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ABSTRACT
Objective: Develop a model that allowed the study of bone 
regeneration in infection conditions. Method: A 15 mm defect 
was surgically created in the rabbit ulna and inoculated with 
5x108 colony-forming units (CFU) of S. aureus. Surgical 
debridement was performed two weeks after and systemic 
gentamicin was administered for four weeks. Animals were 
followed up to 12 weeks to evaluate infection control and 
bone regeneration. Result: Bone regeneration was inferior to 
25% of the defect in radiological and histological analysis. 
Conclusion: Infected bone defect of 15 mm in the rabbit 
ulna was unable to achieve full regeneration without further 
treatment. Level of Evidence V, Experimental Study.
Keywords: Bone diseases. Infectious. Bone regeneration. 
Rabbits.
INTRODUCTION
The loss of large bone segments remains one of the most 
challenging problems in orthopedic surgery,1,2 and is frequently 
associated with infection.2-5 Experimental models are useful 
for assessing the efficacy of new treatments, and should be 
reproducible, well controlled and afford the application of stan-
dardized methods of analysis.6
Evans, Nelson and Harrison7 described a method for creating 
experimental infection in rabbit forearms, which has become 
one of the most important for studying osteomyelitis. However, 
in this model infection produces alterations in the bone architec-
ture such as osteolysis, sequestration, sclerosis and diaphyseal 
enlargement,7,8 which render it unsuitable for analyzing regene-
ration. The aim of this study was to develop a model of infected 
bone gap/defect that would allow the adequate evaluation of 
bone regeneration.
MATERIAL AND METHODS
Staphylococcus aureus inoculum
Samples of the selected strain were seeded in blood agar and 
left in the incubator at a temperature of 35ºC for 24 hours. After 
this period the material was diluted in sterile saline until it rea-
ched the turbidity corresponding to 1010 CFU/ml. A sample of 
the solution was then diluted to 104 and read in the Neubauer 
chamber (Herka Intercolor), confirming the concentration, and 
seeded in CLED agar to test the viability of the inoculum.
Experimental model
The study was approved by the ethics committee in animal 
experimentation of Faculdade de Medicina de Ribeirão Pre-
to da Universidade de São Paulo, and twelve female rabbits 
weighing between 2.5 and 3.5kg were used. The animals were 
anesthetized using ketamine hydrochloride (40mg/Kg) and 
xylazine (8mg/Kg) applied via intramuscular route, followed by 
continuous venous infusion of 1% ketamine. The right ulna was 
exposed surgically and a 15mm bone segment from the distal 
third was resected without the periosteum using a bone saw.
After this the segment was placed back on the defect and 0.05 
cc of the inoculum (5x108 CFU) was introduced into the me-
dullary canal using a 0.3 cc syringe. The periosteum and skin 
were sutured closed and analgesia with ketoprofen (2/mg/Kg 
IM) was performed for three days after each surgical procedure.
Two weeks later the wound was debrided, the bone fragment 
collected for culturing, all the necrotic tissues removed and 
the wound cleaned with 40ml of 0.9% sterile saline solution. 
Two animals were euthanized soon after the debridement, and 
the others received 6mg/Kg/day IM gentamicin for four weeks. 
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The bone fragment collected in debridement was cultivated 
on blood agar and tested for antimicrobial sensitivity (Walka-
way-96, Baxter Diagnostics Inc.).
Administration of fluorochromes was performed in two ani-
mals, alizarin (10mg/Kg) four weeks after debridement, calcein 
(10mg/Kg) at eight weeks and oxytetracycline (10mg/Kg) 48 
hours before euthanasia.
Radiographs were taken after debridement and at 4 and 8 weeks. 
The animals were euthanized after 12 weeks with sodium thio-
pental (50mg/Kg IV) and the piece was submitted to radiography 
with high resolution film (Kodak Insight®).
Radiographic and histological analysis
The infection was evaluated radiographically according to the 
degree of destruction of the bone architecture and of the perios-
teum9 and regeneration based on the size of the bone defect 
and on the void filling percentage. 
For histology the region of the bone void was decalcified with 
7.5% nitric acid, soaked in paraffin and sectioned lengthwise. 
Hematoxylin-eosin and Gram were used for staining.10,11 The 
samples with fluorochromes were submitted to dehydration in 
increasing gradations of alcohol and then were embedded in 
acrylic resin. The cross-sections were stained with a mixture of 
methylene blue, azure II and pararosaniline or left unstained for 
fluorescence.12 The histological analysis used the scale descri-
bed by Ambrose et al.11
Statistics
SPSS 15.0 software was used for data analysis with significance 
level of p = 0.05.
RESULTS
Eleven wounds (92%) had clinical signs of infection at the time 
of debridement. The average size of the bone defect measured 
in the intraoperative period, increased from 15mm before the 
inoculum to 16 mm after debridement (p = 0.01). Two animals 
died during the follow-up of causes not related to the study. 
After 12 weeks all the wounds were healed and without signs of 
infection. S. aureus was the only agent isolated in the samples 
analyzed. Periosteal reaction was observed on the borders of 
the bone void in 58% of the animals in the initial radiographs, 
considered secondary to surgical handling and not to infection. 
No radiographic alterations related to infection were observed 
at the end of study. The average length of the bone defect 
decreased from 16mm after debridement to 11mm at the end 
of the follow-up. Union (defined as bone regeneration above 
25% of the defect) occurred in only one fourth of the bone 
voids. The mean percentage of gap filling rose from 3% in the 
fourth week after debridement to 6% after 12 weeks. (Figure 1) 
The presence of bacteria was not observed in the histological 
control, yet signs of intraosseus inflammation were identified 
according to Table 1. After 12 weeks the percentage of void 
filling was below 25%, with most of the regenerate material 
originating from the periosteum of the intraosseus membra-
ne. The fluorescence showed that bone deposition occurred 
predominantly during the first four weeks, and was minimal at 
12 weeks. (Figure 2) 
DISCUSSION
Rabbit ulna segmental bone defect is a well-established model 
in the study of bone regeneration.13-19 Inocula ranging between 
105-108 in a segment of devitalized bone produce infection rates 
Figure 1. (A) – Wound before the debridement. (B) – Bone void after debridement. (C) – Wound at 12 weeks (D) –  Incomplete regeneration of the bone void 
at 12 weeks.
Table 1. Results of the histological analysis.
Histological grading scale 
Categories Debridement 12 weeks 
Presence of intraosseous bacteria 
Yes 100% 0
No 0 100%
Intraosseous inflammation 
Severe 100% 50%
Moderate 25%
Mild 25%
None 0
Bone Neoformation 
Minimal < 25% 100% 38%
Mild 25-50% 38%
Moderate 50-75% 24%
Total 75-100% 0
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Figure 2. (A) – Longitudinal section showing unfilled bone void and 
predominant deposition along the radial border (methylene blue, azure II, 
pararosaniline) bone 2.5x. (B) – Bone regeneration in the 4th week (alizarin) 
2.5 x. (C) – Bone regeneration in the 12th (oxytetracycline) 2.5 x.
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above 90%, with the time to debridement ranging from two to 
four weeks.7,8,11 Longer periods are associated with intense 
destruction of the bone architecture and disorganized periosteal 
reaction, with the infection extending through the bone,7,8,11,20,21 
hindering the radiographic and histological evaluation of rege-
neration.
In this study infection was obtained in 100% of the animals 
without important destruction of the bone architecture after two 
weeks. With debridement there was an increase in the bone void 
and four weeks of systemic antibiotics were sufficient to control 
the infection, with no signs of recurrence during follow-up. After 
12 weeks the bone regeneration of the void was below 25% both 
in the radiologic and histological evaluation.
CONCLUSION
An infected bone void of 15 millimeters in rabbit ulna can be 
considered a “critical void” since spontaneous regeneration 
is not achieved. This model proved to be predictable and well 
controlled, and as such, appropriate for studying bone rege-
neration under infection conditions.
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